Cargando…

Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report

Solitary fibrous tumor (SFT) is a rare spindle cell tumor, benign or low-grade malignant, with an extremely low possibility of occurrence of malignant solitary fibrous tumor (MSFT). Surgery is an effective way for treating SFT, but it is often difficult to resect completely due to a large size, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhen, Yu, Huimin, Di, Xuemin, Zhao, Jinxin, Liang, Yansong, Liu, Zezhou, Wang, Juan, Zhang, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376293/
https://www.ncbi.nlm.nih.gov/pubmed/35978802
http://dx.doi.org/10.3389/fonc.2022.884491
_version_ 1784768134294536192
author Gao, Zhen
Yu, Huimin
Di, Xuemin
Zhao, Jinxin
Liang, Yansong
Liu, Zezhou
Wang, Juan
Zhang, Hongtao
author_facet Gao, Zhen
Yu, Huimin
Di, Xuemin
Zhao, Jinxin
Liang, Yansong
Liu, Zezhou
Wang, Juan
Zhang, Hongtao
author_sort Gao, Zhen
collection PubMed
description Solitary fibrous tumor (SFT) is a rare spindle cell tumor, benign or low-grade malignant, with an extremely low possibility of occurrence of malignant solitary fibrous tumor (MSFT). Surgery is an effective way for treating SFT, but it is often difficult to resect completely due to a large size, with a high recurrence rate and mortality rate after operation. Additionally, SFT is relatively resistant to chemotherapy, and there is a lack of effective systemic drug treatment. These lead to certain difficulties in the treatment of SFT. We report a case of a rare MSFT in the pelvic cavity. With a history of recurrence after two surgeries, this patient underwent surgical removal combined with (125)I seed implantation at our hospital in the context that the tumor could not be completely removed because it was large and adhered to surrounding tissues; after up to 43 months of progression-free survival (PFS), the patient underwent (125)I seed implantation alone, and achieved a complete remission, with a PFS up to 35 months. (125)I seed implantation can be a safe and effective treatment option for unresectable MSFT as well as a potential solution to repeated local recurrence.
format Online
Article
Text
id pubmed-9376293
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93762932022-08-16 Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report Gao, Zhen Yu, Huimin Di, Xuemin Zhao, Jinxin Liang, Yansong Liu, Zezhou Wang, Juan Zhang, Hongtao Front Oncol Oncology Solitary fibrous tumor (SFT) is a rare spindle cell tumor, benign or low-grade malignant, with an extremely low possibility of occurrence of malignant solitary fibrous tumor (MSFT). Surgery is an effective way for treating SFT, but it is often difficult to resect completely due to a large size, with a high recurrence rate and mortality rate after operation. Additionally, SFT is relatively resistant to chemotherapy, and there is a lack of effective systemic drug treatment. These lead to certain difficulties in the treatment of SFT. We report a case of a rare MSFT in the pelvic cavity. With a history of recurrence after two surgeries, this patient underwent surgical removal combined with (125)I seed implantation at our hospital in the context that the tumor could not be completely removed because it was large and adhered to surrounding tissues; after up to 43 months of progression-free survival (PFS), the patient underwent (125)I seed implantation alone, and achieved a complete remission, with a PFS up to 35 months. (125)I seed implantation can be a safe and effective treatment option for unresectable MSFT as well as a potential solution to repeated local recurrence. Frontiers Media S.A. 2022-08-01 /pmc/articles/PMC9376293/ /pubmed/35978802 http://dx.doi.org/10.3389/fonc.2022.884491 Text en Copyright © 2022 Gao, Yu, Di, Zhao, Liang, Liu, Wang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gao, Zhen
Yu, Huimin
Di, Xuemin
Zhao, Jinxin
Liang, Yansong
Liu, Zezhou
Wang, Juan
Zhang, Hongtao
Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title_full Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title_fullStr Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title_full_unstemmed Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title_short Case report: (125)I seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
title_sort case report: (125)i seed implantation for rare malignant solitary fibrous tumor in the pelvic cavity: a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376293/
https://www.ncbi.nlm.nih.gov/pubmed/35978802
http://dx.doi.org/10.3389/fonc.2022.884491
work_keys_str_mv AT gaozhen casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT yuhuimin casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT dixuemin casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT zhaojinxin casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT liangyansong casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT liuzezhou casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT wangjuan casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport
AT zhanghongtao casereport125iseedimplantationforraremalignantsolitaryfibroustumorinthepelviccavityacasereport